H1N1 Vaccines Market Share

Statistics for the 2023 & 2024 H1N1 Vaccines market share, created by Mordor Intelligence™ Industry Reports. H1N1 Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Finished Dosage Form Research Vaccines Research H1N1 Vaccines Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of H1N1 Vaccines Industry

The H1N1 Vaccines Market is consolidated and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are MedImmune LLC (AstraZeneca PLC), Sanofi Pasteur AG, GlaxoSmithKline Plc, Abbott Laboratories, CSL Limited (Seqirus GmbH), Pfizer Inc, CPL Biologicals Pvt. Ltd, Mitsubishi Tanabe Pharma Corporation, Sinovac Biotech Ltd and Zydus Cadila.

H1N1 Vaccines Market Leaders

  1. AstraZeneca Plc

  2. Sanofi (Sanofi Pasteur AG)

  3. GlaxoSmithKline Plc

  4. Abbott Laboratories

  5. CSL Limited (Seqirus GmbH)

*Disclaimer: Major Players sorted in no particular order

H1N1 Vaccines Market landscape

H1N1 Vaccines Report Snapshots

H1N1 Vaccines Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)